A covalent inhibitor developed against KRAS G12C protein, also called sotorasib. Its state-dependent binding illustrates targeting a mutant small GTPase outside the nucleotide site.[ref]
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity by Jude Canon and others. Chemical and preclinical characterization
New to topics? Read the docs here!